Leave Your Message
-
Email
-
Phone
-
Whatsapp
Phone
In the modern healthcare landscape, medical testing equipment โ from portable blood analyzers and point-of-care diagnostics to advanced patient monitoring systems and wireless ECG devices โ demands power sources that are not merely adequate, but exceptional. Lithium ion batteries have emerged as the definitive standard for this sector, offering an unmatched combination of energy density, cycle life, operational safety, and reliability under demanding clinical conditions.
๐ฅ The global market for lithium ion batteries in medical devices is projected to exceed USD 4.2 billion by 2030, driven by the explosive growth of portable diagnostics, remote patient monitoring, and AI-powered medical instruments.
Unlike conventional alkaline or nickel-based chemistries, lithium ion batteries deliver stable voltage output throughout their discharge cycle โ a property that is essential for the precision sensors and microprocessors inside diagnostic analyzers, infusion pumps, and handheld ultrasound scanners. Even a minor voltage fluctuation can compromise measurement accuracy in clinical settings, making the quality of the battery as critical as any other component in the device.
The medical device industry is one of the fastest-growing end markets for lithium ion battery technology. Global megatrends โ aging populations, the shift toward home-based and remote healthcare, and the proliferation of wearable health monitors โ are collectively driving unprecedented demand for compact, long-lasting, and safe battery solutions.
Major medical device OEMs including Medtronic, Philips, GE Healthcare, and Siemens Healthineers have accelerated their integration of advanced lithium ion cells into next-generation portable equipment. Battery suppliers capable of meeting IEC 62133, UL 1642, and ISO 13485 quality standards are increasingly preferred as strategic partners in device development rather than simple commodity vendors.
โก Cylindrical lithium ion cells โ particularly the 18650, 21700, and 26700 formats โ have become the backbone of medical battery packs due to their standardized form factors, proven safety records, and scalability in PACK configurations.
From a supply chain perspective, the consolidation of battery manufacturing in Asia โ and specifically China โ has created both opportunities and strategic imperatives for global medical device brands. Partnering with a vertically integrated, ISO-certified manufacturer with proven medical-grade production capabilities is now a key competitive differentiator.
From compact handheld analyzers to sophisticated laboratory instruments, lithium ion batteries power every tier of modern medical diagnostics. Here is an in-depth look at the most critical application scenarios.
Point-of-care blood testing devices require batteries that can deliver consistent power for optical sensors, microfluidic pumps, and Bluetooth data transmission simultaneously. The NCM/NCA 18650 25L low-temperature cell excels in this role, maintaining stable performance from โ20ยฐC to 60ยฐC โ critical for field diagnostics in ambulances or cold-climate environments.
Wireless ECG monitors, Holter recorders, and bedside patient monitoring units demand ultra-low self-discharge rates and multi-day operational life. High-capacity 21700 58E cells โ with their industry-leading energy density โ enable devices to operate continuously for 72+ hours on a single charge, transforming remote patient monitoring workflows.
Next-generation handheld ultrasound scanners integrate high-performance processors and transducer arrays that demand peak power bursts during image acquisition. High-rate 18650 25T and 21700 40T cells provide the instantaneous current delivery required for artifact-free imaging, while their long cycle life reduces total cost of ownership for clinical fleets.
Ambulatory infusion pumps are life-critical devices where battery failure is simply not an option. LFP (Lithium Iron Phosphate) chemistry โ as embodied in the 26700 43E cell โ offers inherent thermal stability, zero risk of thermal runaway, and a cycle life exceeding 2,000 cycles, making it the preferred choice for implantable-adjacent and wearable drug delivery systems.
Benchtop IVD analyzers for hematology, immunoassay, and molecular diagnostics increasingly incorporate backup battery systems to prevent data loss and maintain sample integrity during power outages. Large-format battery packs built from 21700 or 26700 cells provide the energy buffer needed for graceful shutdown and UPS functionality in laboratory environments.
The wearable medical device segment โ encompassing continuous glucose monitors, smart patches, and AI-powered biosensors โ represents the frontier of lithium ion battery miniaturization. Polymer lithium cells and compact cylindrical formats enable devices that are lightweight, flexible-form, and capable of weeks of continuous monitoring on a single charge cycle.
Intelligent BMS platforms powered by machine learning are enabling predictive state-of-health monitoring, adaptive charging algorithms, and real-time anomaly detection in medical battery packs. This dramatically reduces unexpected device downtime in clinical settings and extends battery service life by up to 30%.
Solid-state lithium batteries โ offering higher energy density, zero liquid electrolyte leakage risk, and enhanced thermal stability โ are entering early-stage medical device trials. While still premium-priced, they represent the long-term trajectory for implantable and high-reliability diagnostic applications.
Regulatory pressure from the EU Battery Regulation and global ESG mandates is accelerating the adoption of green manufacturing practices. Changhong New Energy's designation as a National Green Factory reflects the industry's shift toward carbon-neutral battery production โ a key procurement criterion for multinational medical device companies.
The COVID-19 pandemic permanently accelerated the shift toward decentralized testing. Portable, battery-powered diagnostic devices are now standard in pharmacies, schools, workplaces, and homes. This structural shift is creating sustained long-term demand for compact, high-performance lithium ion cells across all medical testing equipment categories.
Medical battery suppliers must navigate an increasingly complex global regulatory landscape including IEC 62133-2, UN 38.3 transport testing, FDA 21 CFR Part 820, and MDR 2017/745 in Europe. Manufacturers with embedded quality systems โ including FMEA, traceability, and lot-level testing โ are commanding premium partnerships with tier-1 medical OEMs.
5G-enabled medical instruments transmit real-time patient data to cloud platforms, requiring batteries capable of supporting continuous wireless communication alongside sensor operation. Changhong's inclusion in the MIIT 5G Factory List signals its alignment with the connected healthcare ecosystem โ both in manufacturing intelligence and product capability.
Sichuan Changhong New Energy Technology Co., Ltd. was founded in October 2006. As a subsidiary of Changhong Holding Group (one of the World's Top 500 Brands), it is a national high-tech enterprise integrating R&D, manufacturing and sales of full-range alkaline batteries and lithium-ion batteries.
The company now operates six manufacturing bases in Mianyang (Sichuan), Jiaxing (Zhejiang), Taixing (Jiangsu), Huarong (Hunan), Shenzhen (Guangdong) and Chonburi (Thailand). It has an annual production and sales capacity of 3.5 billion alkaline manganese batteries, 600 million cylindrical lithium-ion batteries (including 18650, 21700, 26700 and other models), over 100 million small polymer batteries and over 100 million battery PACK sets.
It controls three subsidiaries: Zhejiang Changhong Feishi Electrical Appliance Industry Co., Ltd., Changhong Sanjie New Energy Co., Ltd., and Shenzhen Changhong Juheyuan Technology Co., Ltd.
The company is a listed enterprise in China (Stock Code: 920239), Top 100 Chinese Battery Companies, Vice Chairman Unit of China Battery Industry Association, Member of IEC Technical Committee on Primary Batteries, National High-Tech Enterprise, National Specialized, Sophisticated, Unique and New "Little Giant" Enterprise, the largest production base of high-rate cylindrical lithium batteries in Western China, National Green Factory, Sichuan Provincial Advanced Smart Factory, and included in the MIIT 5G Factory List.
Customer-Centered.
Intelligent Manufacturing, Technological Innovation, Benefit Humanity.
Responsibility, Innovation, Commitment.
To Become a World-Class New Energy Enterprise.
Changhong introduced advanced technologies and equipment for alkaline manganese batteries from Toshiba, entering the primary battery sector.
Changhong New Energy was independently registered and officially operated.
Introduced the world's high-end Haiba production line for alkaline batteries.
Changhong Energy listed on the New Third Board; acquired Zhejiang Feishi to build a coastal production and export base.
Acquired Jiangsu Sanjie, entering the cylindrical lithium battery industry.
Established Mianyang Jiechuang, realizing large-scale capacity expansion of alkaline batteries and lithium batteries.
Changhong Energy officially listed on the Beijing Stock Exchange (Stock Code: 920239).
Acquired Shenzhen Juheyuan, entering the polymer lithium battery sector. Changhong Sanjie's cylindrical lithium battery capacity exceeded 500 million units.
Hunan Changhong Juheyuan polymer battery capacity expanded. Preparation for Changhong New Energy Thailand Plant commenced.
Changhong New Energy Thailand Plant officially went into operation. Total alkaline battery capacity exceeded 3.5 billion units.
Partner with a world-class lithium ion battery manufacturer trusted by leading medical device brands globally. Get custom battery solutions engineered to your exact clinical specifications.
Request a Custom Battery Solution โ